Works about ANGIOTENSIN-receptor blockers

Results: 2014
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Prescription-based cost analysis of medicines for cardiovascular risk factors at Indian Council of Medical Research-Rational Use of Medicine Centre Hospitals of India.

    Published in:
    Indian Journal of Pharmacology, 2024, v. 56, n. 2, p. 97, doi. 10.4103/ijp.ijp_61_23
    By:
    • Chugh, Preeta Kaur;
    • Gupta, Pooja;
    • Wasan, Himika;
    • Tripathi, C. D.;
    • Chandy, Sujith J.;
    • Ranjalkar, Jaya;
    • Bright, Heber Rew;
    • Badyal, Dinesh Kumar;
    • Samuel, Madhulika Peter;
    • Jhaj, Ratinder;
    • Banerjee, Aditya;
    • Joshi, Rupa;
    • Medhi, Bikash;
    • Prakash, Ajay;
    • Kamat, Sandhya;
    • Tripathi, Raakhi;
    • Shetty, Yashashri;
    • Parmar, Urwashi;
    • Dikshit, Harihar;
    • Mishra, Hitesh
    Publication type:
    Article
    13

    Olmesartan: Induced maculopapular rash.

    Published in:
    Indian Journal of Pharmacology, 2013, v. 45, n. 2, p. 199, doi. 10.4103/0253-7613.108325
    By:
    • Bhushan, Aruna;
    • Bhushan, S. T. Ved
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21

    The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in elderly (≥ 65) patients with acute myocardial infarction without hypertension.

    Published in:
    Heart & Vessels, 2023, v. 38, n. 7, p. 898, doi. 10.1007/s00380-023-02244-x
    By:
    • Ahn, Woo Jin;
    • Rha, Seung-Woon;
    • Choi, Byoung Geol;
    • Jeong, Myung Ho;
    • Ahn, Tae Hoon;
    • Yoon, Junghan;
    • Kim, Hyo‐Soo;
    • Seung, Ki‐Bae;
    • Gwon, Hyeon‐Cheol;
    • Chae, Shung Chull;
    • Kim, Chong‐Jin;
    • Cha, Kwang Soo;
    • Lee, Jung‐Hee;
    • Chae, Jei Keon;
    • Joo, Seung‐Jae;
    • Yoon, Chang‐Hwan;
    • Hur, Seung‐Ho;
    • Seong, In‐Whan;
    • Hwang, Kyung‐Kuk;
    • Kim, Doo‐Il
    Publication type:
    Article
    22
    23
    24

    Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study

    Published in:
    2020
    By:
    • Imaizumi, Satoshi;
    • Shiga, Yuhei;
    • Ogawa, Masahiro;
    • Sako, Hideto;
    • Nagata, Yoshihisa;
    • Matsunaga, Akira;
    • Shirotani, Tetsuro;
    • Hoshino, Fumihiro;
    • Yahiro, Eiji;
    • Uehara, Yuko;
    • Morito, Natsumi;
    • Tanigawa, Hiroyuki;
    • Shimono, Dai;
    • Fukushima, Mikio;
    • Sugihara, Hidekazu;
    • Norimatsu, Kenji;
    • Kusumoto, Takaaki;
    • Saku, Keijiro;
    • Miura, Shin-ichiro
    Publication type:
    Correction Notice
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Angiotensin receptor blocker use is associated with upregulation of the memory-protective angiotensin type 4 receptor (AT<sub>4</sub>R) in the postmortem brains of individuals without cognitive impairment.

    Published in:
    GeroScience, 2023, v. 45, n. 1, p. 371, doi. 10.1007/s11357-022-00639-8
    By:
    • Cosarderelioglu, Caglar;
    • Nidadavolu, Lolita S.;
    • George, Claudene J.;
    • Marx-Rattner, Ruth;
    • Powell, Laura;
    • Xue, Qian-Li;
    • Tian, Jing;
    • Oh, Esther S.;
    • Ferrucci, Luigi;
    • Dincer, Pervin;
    • Bennett, David A.;
    • Walston, Jeremy D.;
    • Abadir, Peter M.
    Publication type:
    Article
    44
    45
    46

    ARNI Versus Perindopril for Remodeling in HFrEF. A Cohort Study.

    Published in:
    Journal of Cardiovascular Pharmacology & Therapeutics, 2023, v. 28, p. 1, doi. 10.1177/10742484231195019
    By:
    • Bin Atan, Noor Muhammad Azlan Shah;
    • Bin Hadi, Mohd Firdaus;
    • Teoh, Victoria Wen Yeng;
    • Danaee, Mahmoud;
    • Loch, Alexander
    Publication type:
    Article
    47
    48
    49
    50